Kiniksa Pharmaceuticals to Report Third Quarter 2024 Financial Results on October 29, 2024

Core Insights - Kiniksa Pharmaceuticals International, plc will host a conference call and live webcast on October 29, 2024, at 8:30 a.m. Eastern Time to discuss its Q3 2024 financial results and recent portfolio execution [1] - The conference call will be accessible via the company's website, and participants can register to receive dial-in details [1] - A replay of the event will be available on Kiniksa's website approximately 48 hours after the call [1] Company Overview - Kiniksa is a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients with significant unmet medical needs [2] - The company's immune-modulating assets are based on strong biological rationale or validated mechanisms, targeting underserved cardiovascular and autoimmune conditions [2] - Kiniksa aims to offer differentiated therapeutic options in its market [2]